GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 157.93 Million CNY | 159.41% |
| 2022 | -200.54 Million CNY | 7.23% |
| 2021 | -316.34 Million CNY | -320.38% |
| 2020 | 44.06 Million CNY | -47.51% |
| 2019 | 206.53 Million CNY | -46.89% |
| 2018 | 514.89 Million CNY | 61.15% |
| 2017 | 319.5 Million CNY | 55.27% |
| 2016 | 203.7 Million CNY | 531.56% |
| 2015 | 34.48 Million CNY | -51.32% |
| 2014 | 53.18 Million CNY | 338.56% |
| 2013 | -7.86 Million CNY | -97.01% |
| 2012 | 485.85 Million CNY | 18.54% |
| 2011 | 307.47 Million CNY | 32.76% |
| 2010 | 228.55 Million CNY | 2137.75% |
| 2009 | -30.22 Million CNY | -102.25% |
| 2008 | 550.65 Million CNY | 213.36% |
| 2007 | -741.21 Million CNY | -544.11% |
| 2006 | 156.44 Million CNY | 0.7% |
| 2005 | 142.88 Million CNY | 26.12% |
| 2004 | 110.94 Million CNY | -0.75% |
| 2003 | 101.5 Million CNY | -2.46% |
| 2002 | 114.59 Million CNY | 48.9% |
| 2001 | 80.92 Million CNY | -1.74% |
| 2000 | 77.13 Million CNY | 94.95% |
| 1999 | 40.17 Million CNY | 57.03% |
| 1998 | 25.58 Million CNY | 82.77% |
| 1997 | 13.99 Million CNY | -13.71% |
| 1996 | 16.22 Million CNY | -0.8% |
| 1995 | 16.35 Million CNY | 154.66% |
| 1994 | 6.42 Million CNY | 27.45% |
| 1993 | 5.03 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 18.34 Million CNY | -75.12% |
| 2024 Q1 | 56.47 Million CNY | 1189.43% |
| 2024 Q3 | 22.61 Million CNY | 31.37% |
| 2023 Q4 | 5.36 Million CNY | -74.08% |
| 2023 Q1 | 19.31 Million CNY | 106.52% |
| 2023 FY | - CNY | 159.41% |
| 2023 Q2 | 13.1 Million CNY | -32.14% |
| 2023 Q3 | 20.69 Million CNY | 57.93% |
| 2022 Q3 | -49.44 Million CNY | -634.53% |
| 2022 Q2 | -6.73 Million CNY | -133.97% |
| 2022 Q1 | 19.81 Million CNY | 107.59% |
| 2022 Q4 | -296.35 Million CNY | -499.39% |
| 2022 FY | - CNY | 7.23% |
| 2021 Q4 | -261.03 Million CNY | -329.53% |
| 2021 Q1 | 15.71 Million CNY | 176.78% |
| 2021 Q3 | -60.77 Million CNY | -24.94% |
| 2021 FY | - CNY | -320.38% |
| 2021 Q2 | -48.63 Million CNY | -409.46% |
| 2020 Q3 | 26.81 Million CNY | 6.65% |
| 2020 FY | - CNY | -47.51% |
| 2020 Q1 | 35.59 Million CNY | 564.46% |
| 2020 Q2 | 25.14 Million CNY | -29.36% |
| 2020 Q4 | 5.67 Million CNY | -78.82% |
| 2019 FY | - CNY | -46.89% |
| 2019 Q1 | 77.04 Million CNY | -61.54% |
| 2019 Q2 | 83.92 Million CNY | 8.94% |
| 2019 Q4 | -7.66 Million CNY | -109.82% |
| 2019 Q3 | 78 Million CNY | -7.06% |
| 2018 Q4 | 200.33 Million CNY | 91.23% |
| 2018 Q2 | 127.34 Million CNY | 83.72% |
| 2018 FY | - CNY | 61.15% |
| 2018 Q1 | 69.31 Million CNY | -57.98% |
| 2018 Q3 | 104.75 Million CNY | -17.74% |
| 2017 FY | - CNY | 55.27% |
| 2017 Q4 | 164.95 Million CNY | 414.93% |
| 2017 Q3 | 32.03 Million CNY | -57.52% |
| 2017 Q2 | 75.41 Million CNY | 106.66% |
| 2017 Q1 | 36.49 Million CNY | -59.3% |
| 2016 Q3 | 41.06 Million CNY | 10.7% |
| 2016 Q2 | 37.09 Million CNY | 28.6% |
| 2016 Q4 | 89.65 Million CNY | 118.33% |
| 2016 Q1 | 28.84 Million CNY | 23.67% |
| 2016 FY | - CNY | 531.56% |
| 2015 FY | - CNY | -51.32% |
| 2015 Q2 | 18.75 Million CNY | 328.24% |
| 2015 Q4 | 23.32 Million CNY | 1167.58% |
| 2015 Q3 | -2.18 Million CNY | -111.65% |
| 2015 Q1 | -8.21 Million CNY | -120.66% |
| 2014 Q2 | 25.46 Million CNY | 375.97% |
| 2014 Q1 | -9.22 Million CNY | -127.51% |
| 2014 FY | - CNY | 338.56% |
| 2014 Q4 | 39.77 Million CNY | 877.96% |
| 2014 Q3 | 4.06 Million CNY | -84.03% |
| 2013 Q4 | 33.54 Million CNY | 389.84% |
| 2013 FY | - CNY | -97.01% |
| 2013 Q3 | -11.57 Million CNY | -237.73% |
| 2013 Q2 | 8.4 Million CNY | 86.98% |
| 2013 Q1 | 4.49 Million CNY | -99.09% |
| 2012 FY | - CNY | 18.54% |
| 2012 Q2 | -14.17 Million CNY | -1633.05% |
| 2012 Q3 | -579.74 Thousand CNY | 95.91% |
| 2012 Q4 | 496.12 Million CNY | 85676.77% |
| 2012 Q1 | -818.05 Thousand CNY | -100.18% |
| 2011 Q2 | 252.19 Million CNY | 2076.54% |
| 2011 Q1 | -12.75 Million CNY | -103.88% |
| 2011 Q3 | -10.5 Million CNY | -104.17% |
| 2011 Q4 | 449.15 Million CNY | 4375.65% |
| 2011 FY | - CNY | 32.76% |
| 2010 Q1 | -7.99 Million CNY | -252.59% |
| 2010 Q2 | 4.03 Million CNY | 150.45% |
| 2010 Q3 | -12.13 Million CNY | -400.87% |
| 2010 Q4 | 328.62 Million CNY | 2809.15% |
| 2010 FY | - CNY | 2137.75% |
| 2009 FY | - CNY | -102.25% |
| 2009 Q1 | -8.24 Million CNY | -101.17% |
| 2009 Q2 | -10.9 Million CNY | -32.27% |
| 2009 Q3 | -21.54 Million CNY | -97.58% |
| 2009 Q4 | 5.23 Million CNY | 124.31% |
| 2008 Q3 | -90.83 Million CNY | -276.92% |
| 2008 Q4 | 701.99 Million CNY | 872.79% |
| 2008 Q2 | 51.34 Million CNY | 49.73% |
| 2008 Q1 | 34.29 Million CNY | 104.94% |
| 2008 FY | - CNY | 213.36% |
| 2007 FY | - CNY | -544.11% |
| 2007 Q2 | 29.55 Million CNY | 8.59% |
| 2007 Q1 | 27.21 Million CNY | 16.56% |
| 2007 Q3 | 17.43 Million CNY | -41.0% |
| 2007 Q4 | -694.88 Million CNY | -4085.43% |
| 2006 Q1 | 43.26 Million CNY | 1.31% |
| 2006 Q4 | 23.34 Million CNY | -7.8% |
| 2006 Q3 | 25.32 Million CNY | -53.73% |
| 2006 Q2 | 54.72 Million CNY | 26.49% |
| 2006 FY | - CNY | 0.7% |
| 2005 Q2 | 35.35 Million CNY | -6.49% |
| 2005 FY | - CNY | 26.12% |
| 2005 Q1 | 37.8 Million CNY | 794.66% |
| 2005 Q3 | 34.95 Million CNY | -1.12% |
| 2005 Q4 | 42.71 Million CNY | 22.2% |
| 2004 Q2 | 32.61 Million CNY | -17.17% |
| 2004 Q1 | 39.37 Million CNY | 210.11% |
| 2004 FY | - CNY | -0.75% |
| 2004 Q4 | 4.22 Million CNY | -85.57% |
| 2004 Q3 | 29.27 Million CNY | -10.25% |
| 2003 Q2 | 26.52 Million CNY | -33.24% |
| 2003 FY | - CNY | -2.46% |
| 2003 Q1 | 39.73 Million CNY | 42.24% |
| 2003 Q4 | 12.69 Million CNY | -53.17% |
| 2003 Q3 | 27.11 Million CNY | 2.22% |
| 2002 Q2 | 20.04 Million CNY | 27.08% |
| 2002 FY | - CNY | 48.9% |
| 2002 Q3 | 26.79 Million CNY | 33.72% |
| 2002 Q4 | 27.93 Million CNY | 4.23% |
| 2002 Q1 | 15.77 Million CNY | 0.0% |
| 2001 FY | - CNY | -1.74% |
| 2000 FY | - CNY | 94.95% |
| 1999 FY | - CNY | 57.03% |
| 1998 FY | - CNY | 82.77% |
| 1997 FY | - CNY | -13.71% |
| 1996 FY | - CNY | -0.8% |
| 1995 FY | - CNY | 154.66% |
| 1994 FY | - CNY | 27.45% |
| 1993 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 97.149% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 95.583% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | 86.004% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | 18.058% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 130.983% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 1219.211% |
| NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 90.247% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | 89.856% |